Literature DB >> 30855761

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. Reply.

Scott J Antonia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30855761     DOI： 10.1056/NEJMc1900407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.

Authors:  Puneeth Iyengar; Elizabeth Zhang-Velten; Laurence Court; Kenneth Westover; Yulong Yan; Mu-Han Lin; Zhenyu Xiong; Mehul Patel; Douglas Rivera; Joe Chang; Mark Saunders; Anand Shivnani; Andrew Lee; Randall Hughes; David Gerber; Jonathan Dowell; Ang Gao; John Heinzerling; Ying Li; Chul Ahn; Hak Choy; Robert Timmerman
Journal:  JAMA Oncol       Date:  2021-10-01       Impact factor: 33.006

2.  The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non-Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review.

Authors:  Qing-Qing Chai; Jiang-Yang Du; Jun Zhu; Bin Wu
Journal:  Front Pharmacol       Date:  2019-10-24       Impact factor: 5.810

Review 3.  Modeling of radiation effects to immune system: a review.

Authors:  Wonmo Sung; Byungchul Cho
Journal:  J Korean Phys Soc       Date:  2022-08-08       Impact factor: 0.657

4.  Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target.

Authors:  Said Farschtschi; Lan Kluwe; Su-Jin Park; Su-Jun Oh; Nancy Mah; Victor-Felix Mautner; Andreas Kurtz
Journal:  Cancer Immunol Immunother       Date:  2020-03-19       Impact factor: 6.968

Review 5.  Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.

Authors:  Oscar Arrieta; Andrés F Cardona; Luis Lara-Mejía; David Heredia; Feliciano Barrón; Zyanya Lucia Zatarain-Barrón; Francisco Lozano; Vladmir Cordeiro de Lima; Federico Maldonado; Francisco Corona-Cruz; Maritza Ramos; Luis Cabrera; Claudio Martin; Luis Corrales; Mauricio Cuello; Marisol Arroyo-Hernández; Enrique Aman; Ludwing Bacon; Renata Baez; Sergio Benitez; Antonio Botero; Mauricio Burotto; Christian Caglevic; Gustavo Ferraris; Helano Freitas; Diego Lucas Kaen; Sebastián Lamot; Gustavo Lyons; Luis Mas; Andrea Mata; Clarissa Mathias; Alvaro Muñoz; Ana Karina Patane; George Oblitas; Luis Pino; Luis E Raez; Jordi Remon; Leonardo Rojas; Christian Rolfo; Alejandro Ruiz-Patiño; Suraj Samtani; Lucia Viola; Santiago Viteri; Rafael Rosell
Journal:  Crit Rev Oncol Hematol       Date:  2020-06-20       Impact factor: 6.312

6.  MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.

Authors:  Qin Li; Xingping Wu; Lin Guo; Jiaxin Shi; Jiashu Li
Journal:  FEBS Open Bio       Date:  2019-10-24       Impact factor: 2.693

Review 7.  First line Immunotherapy for Non-Small Cell Lung Cancer.

Authors:  Nicola J Nasser; Miguel Gorenberg; Abed Agbarya
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.